title: The Revised European-American Classification of Lymphoid Neoplasms (REAL): a new perspective for the classification of cutaneous lymphomas.
abstract: Differing classification schemes for malignant lymphomas have been used in Europe and the United States. Attempts to translate between the principle classifications have been unsuccessful and historically it has been difficult to arrive at an unified approach. In addition, many new lymphoma entities have been recognized in recent years that are not delineated in any of the existing classification schemes. To provide a unified international basis for clinical and investigative work in this field, in 1994 the International Lymphoma Study Group (ILSG) proposed a new classification termed Revised European-American Classification of Lymphoid Neoplasms (REAL). This review discusses the REAL classification, especially as it pertains to cutaneous lymphomas, and provides insight into the clinicopathologic features of lymphoproliferative disease involving the skin. The premise of the REAL classification is that a classification scheme should be based on the delineation of disease entities, utilizing pathologic, immunophenotypic, genetic, and clinical features. Therefore, if cutaneous involvement is an integral aspect of any lymphoma subtype, this clinical information is included in the definition of that neoplasm. We conclude that the principles of the REAL classification are applicable to cutaneous lymphomas, as well as lymphomas involving other anatomic sites.
authors.affiliation: Department of Dermatology, Ludwig-Maximilians-Universitaet, Munich, Germany.
authors.forename: C A
authors.initials: CA
authors.lastname: Sander
authors.forename: P
authors.initials: P
authors.lastname: Kind
authors.forename: P
authors.initials: P
authors.lastname: Kaudewitz
authors.forename: M
authors.initials: M
authors.lastname: Raffeld
authors.forename: E S
authors.initials: ES
authors.lastname: Jaffe
mesh_terms: D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000145:classification; D008223:Lymphoma / Q000145:classification*; D016393:Lymphoma, B-Cell / Q000145:classification; D008224:Lymphoma, Follicular / Q000145:classification; D016399:Lymphoma, T-Cell / Q000145:classification; D012751:Sezary Syndrome / Q000145:classification; D012878:Skin Neoplasms / Q000145:classification*